Pigmentary disorders

The Medical Clinics of North America
Paul T Rose

Abstract

A large number of pigmentary disorders exist and although not all dermatologic entities are covered in this article, some of the pigmentary disorders that an internist or general practitioner is likely to encounter are reviewed. The clinician must be able to recognize pigmentary changes that suggest a serious underlying disease. In a situation where a malignancy or other serious illness may exist, an extensive evaluation to detect the disorder is required. This approach can allow for early treatment and referral to an appropriate specialist if necessary. The clinician must also recognize that pigmentary disorders that are essentially cosmetic still cause concern for the patient and can be emotionally distressing. These patients need emotional support and in some cases referral to a mental health specialist.

References

Feb 1, 1978·The Journal of Dermatology·A B Lerner, J J Nordlund
Aug 1, 1988·Journal of the American Academy of Dermatology·J L Bolognia, J M Pawelek
Mar 17, 1988·The New England Journal of Medicine·R L Martuza, R Eldridge
Jul 1, 1968·Archives of Dermatology·T B FitzpatrickM H Greenberg
Jul 1, 1995·The British Journal of Dermatology·S D ChuangJ T Lin
Oct 1, 1996·Journal of the American Academy of Dermatology·L A DrakeH R Minus
Oct 9, 1998·Journal of Cutaneous Pathology·M L WallaceC R Shea
May 8, 1999·Clinical and Experimental Dermatology·E S DuttonR A Graham-Brown
Jun 12, 1999·Journal of the American Academy of Dermatology·M Landau, B R Krafchik
Oct 31, 2002·Journal of Child Neurology·J M Friedman
Oct 31, 2002·Journal of Child Neurology·Tena Rosser, Roger J Packer
Nov 14, 2002·Journal of the European Academy of Dermatology and Venereology : JEADV·M Blessmann WeberT Ferreira Cestari
Mar 8, 2003·Pigment Cell Research·Katia OngenaeJean-Marie Naeyaert
Jul 16, 2003·Pigment Cell Research·Yvon GauthierAlain Taïeb
Jan 20, 2004·Dermatology : International Journal for Clinical and Investigative Dermatology·R PartapB Kumar
Feb 28, 2004·Clinical and Experimental Dermatology·M EspositoS Chimenti
Mar 11, 2004·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Soni NandaBelum S N Reddy
Jul 10, 2004·Journal of the American Academy of Dermatology·Pearl E GrimesAllan Metzger
Mar 4, 2006·Current Opinion in Infectious Diseases·Vicente Crespo-Erchiga, Vicente Delgado Florencio
Jul 31, 2007·Dermatologic Clinics·Ilse MolletJean-Marie Naeyaert
Jul 31, 2007·Dermatologic Clinics·Jana HercogováTorello Lotti

❮ Previous
Next ❯

Citations

Jul 20, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Yan YeZhi-Ling Yu
Aug 25, 2015·Journal of Ethnopharmacology·Patrícia Mazureki CamposMichel Fleith Otuki
Jul 25, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Se-Hui JungKooyeon Lee
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Se-Hui JungKooyeon Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.